ONO-6950 + Placebo + Montelukast

Phase 2Completed
0 watching 0 views this week Active
52
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma

Trial Timeline

Jun 1, 2012 → —

About ONO-6950 + Placebo + Montelukast

ONO-6950 + Placebo + Montelukast is a phase 2 stage product being developed by Ono Pharmaceutical for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT01551147. Target conditions include Asthma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01551147Phase 2Completed